Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2003
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003CN1454206A 2-enamino-cetonitriles substitues par phenyle
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453265A Aromatic amino acid derivative and its prepn process and medicinal use
11/05/2003CN1126777C Rubber composition containing anti-vukanizing revert material and components of tyre composed therewith
11/05/2003CN1126734C Supercritical CO2 extraction process of capsaicine compounds
11/04/2003US6642392 Pyrrole derivatives
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6641802 Copper sulfat complexes to amino acid
11/04/2003US6641784 Tris-(2,3-epoxypropyl)isocyanurate, is presented. The optical resolver comprises an optically active tris-(epoxyalkyl) isocyanurate or its derivative, or an optically active derivative of a tris-(epoxyalkyl)isocyanurate, High
10/2003
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003047508A3 Paclitaxel solvates
10/30/2003WO2003040149A3 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes
10/30/2003WO2003026415A3 Insecticidal diamides
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204104 Perfluoroalkylated aniline compound and process for producing the same
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1355912A1 Ligands and their use
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1141374B1 Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452473A Container assembly for fertilization and culture and embryo transfer and method for fertilization and culture employing such container
10/29/2003CN1125810C Process of producing formamide
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/28/2003US6639023 Fluorophenyl resin compounds
10/28/2003US6638497 Method of manufacturing quat-containing compositions with improved transportation efficiency and/or processing properties
10/28/2003CA2233792C Process to chloroketones using oxazolines
10/28/2003CA2154558C Process for preparing c-substituted diethylene triamines
10/23/2003WO2003087039A1 Novel nateglinide crystal
10/23/2003WO2003087038A1 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003US20030199713 Catalyst for asymmetric (transfer) hydrogenation
10/23/2003US20030199589 Anticonvulsant and central nervous system-depressing bis (fluorophenyl) alkylamides and their uses
10/23/2003US20030199578 Naphthalene amides as potassium channel openers
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030198658 Mixture of diketopiperazine and active materials; administering by mouth
10/23/2003CA2482669A1 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
10/23/2003CA2481313A1 Bicyclic amides
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1354872A1 Sulfuric acid ester amine salts, sulfonic acid amine salts, production thereof and softener composition
10/22/2003EP1354870A1 Dihydroceramide desaturase inhibitors.
10/22/2003EP1354869A1 Process for producing quaternary ammonium salt having ester group
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003CN1450859A Methods of blocking an ethylene response in plants using cyclopropene derivatives
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125040C Therapeutic compound-fatty acid conjugates
10/22/2003CN1125039C Process for rectifying recovery of diluted dimethyl formamide liquid generated in synthesizing artificial leather by wet method
10/22/2003CN1125023C Substance for inducing cell death
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635784 Process for the preparation of enantiomerically-enriched cyclopropylalanine derivates
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/16/2003WO2003084971A1 Bisphosphines as bidentate ligands
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084541A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195373 Novel beta-hydroxyamides
10/16/2003US20030195369 Optically active chiral diphosphine ligands
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195358 Process for production of gabapentin intermediate
10/16/2003US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030194371 Nuclear magnetic resonance (NMR) diagnosis and radiotherapy
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481037A1 Bisphosphines as bidentate ligands
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/15/2003EP1352900A1 Process to prepare taxol
10/15/2003EP1352899A1 Process to prepare taxol
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352243A2 Perfluoro sulfonyl halides and related species as polymer support modifiers
10/15/2003EP1351905A2 Polymerizable higher diamondoid derivatives
10/15/2003CN1449377A Inhibitors of alpha4 mediated cell adhesion
10/15/2003CN1449376A Process for the production of crystals of a benzoic acid derivative
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124263C Stabilised monomer composition
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632954 Chelate compounds
10/14/2003US6632953 Metal complex comprising a phospholane as claimed in any of claim 1 and a central atom selected from the group of Rh, Ru, Ir, Pd, Pt, Ni. asymmetric hydrogenation of compounds by reacting the starting compounds to be hydrogenated with
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/09/2003WO2003082954A1 Process for production of molecular devices
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 289